STAT May 9, 2024
Annalisa Merelli

Weeks after the global public health community sounded the alarm on the shortage of cholera vaccine, the World Health Organization moved to prequalify a new cholera vaccine last month. The vaccine is a simplified version of the two existing oral vaccines, both produced by Korean vaccine manufacturer EuBiologics Co.

The company will begin making the new vaccine, called Euvichol-S, this year. “We simplified the formulation, which reduces the complexity, the cost, and the time for producing the vaccine,” said Julia Lynch, the director of the cholera program at the International Vaccine Institute, a nonprofit that codeveloped the cholera vaccines with EuBiologics Co. “With this simplified formulation, it’s expected that we’ll increase the production capacity by about 40% — using the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
Measles Is Preventable. How Did the World End Up Back Here?
The voice that saved lives: a doctor’s pandemic hero
Opinion: Readers respond to H5N1 and livestock movements, insulin discontinuation, and more
AstraZeneca antibody reduced Covid-19 risk in immunocompromised
Opinion: H5N1 doesn’t have to be a repeat of Covid-19’s ‘public health versus the economy’

Share This Article